CPC A61N 5/10 (2013.01) [A61B 17/3205 (2013.01); A61K 31/4439 (2013.01); A61K 31/513 (2013.01); A61K 35/00 (2013.01); A61N 5/062 (2013.01); A61N 5/0616 (2013.01); A61P 17/02 (2018.01); A61P 35/00 (2018.01); A61B 18/0218 (2013.01); A61B 2017/00761 (2013.01); A61N 5/067 (2021.08); A61N 2005/0663 (2013.01)] | 20 Claims |
1. A method for treating clinical or pre-clinical skin damage in a skin field of a subject, wherein the skin field has been allocated a skin cancerization field index (SCFI) score of at least 1 or a score of equivalent weighting as determined by a process comprising the steps of:
(a) selecting and assessing at least one skin field for
(i) the number of keratoses in the skin field;
(ii) the thickness of the thickest keratosis in the skin field; and
(iii) the proportion of the skin field affected by clinical or subclinical skin damage;
(b) assigning a score of 0 to 3 for assessment (i), a score of 0 to 3 for assessment (ii), and a score of 0 to 5 for assessment (iii) or scores of equivalent weighting for any of (i)-(iii); and
(c) adding the score for assessment (i) to the score for assessment (ii) and then multiplying the sum of those scores by the score for assessment (iii) to obtain the SCFI score;
the method for treating comprising:
(A) treating the skin field with a field therapy when the SCFI score is 10 or greater or a score of equivalent weighting; or
(B) treating the skin field with a lesional therapy when the SCFI score is 1 to 9 or a score of equivalent weighting.
|